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ing author. Department
rsity Medical Center, 30
. Tel.: +1 650 858 3917;
ess: jfann@stanford.edSummary We evaluated an endobronchial valve device in the treatment of
surgically created air leak or pneumothorax by eliminating antegrade flow.
Methods: Six sheep underwent general anesthesia with positive pressure ventilation
and left thoracotomy. After division of the mediastinal pleura, the contralateral
cranial lobe was identified and a 2.5 cm 1.5 cm laceration created with resultant
air leak. Using bronchoscopy, we deployed a valve device in the bronchus of the
injured segment. Chest drainage tube was placed and the thoracotomy closed. At 1
week (n ¼ 3) and 4 weeks (n ¼ 3), the animals underwent general anesthesia,
bronchoscopy and right thoracotomy.
Results: All animals survived the procedure. Bronchoscopic valve device placement
in the segmental bronchus resolved the air leak immediately. After closure of
thoracotomy, the chest tube demonstrated minimal drainage with no air leak. At 1
and 4 weeks, bronchoscopy showed no change in device location, and the treated
segments were atelectatic with fibrous scar at the injured site.
Conclusions: Collapse of a selected lung segment with resolution of air leak can be
achieved using bronchoscopically implanted valve device. The valve device may
facilitate treatment of patients with post-surgical or post-traumatic persistent air
leak.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserve
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u (J.I. Fann).Introduction
Bronchopleural fistula is one of the most serious
complications after pulmonary resection, with an
incidence of 1% after lobectomy and between 1% and
12% after pneumonectomy.1–5 Traditional therapyd.
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decortication, thoracoplasty, and muscle pedicle
closure. Various bronchoscopic approaches to fistula
closure have been employed in selected patients,
including the use of tissue and fibrin glues and
sealants, stents, plugs, balloons, coils, and submu-
cosal injection of ethanol.6–14 In patients with larger
bronchopleural fistulas, however, bronchoscopic
techniques are less efficacious.
Thoracic injuries occur in 30–40% of trauma
patients requiring hospitalization.15–17 Post-trau-
matic pneumothorax may result from direct lung
puncture, lung lacerations from rapid deceleration,
crush injury with alveolar disruption, and alveolar
ruptures from increased intrathoracic pres-
sure.15–17 In patients with persistent post-traumatic
pneumothorax, a less invasive approach using
video-assisted thoracoscopic surgery has been
shown to be a reliable alternative to an open
thoracotomy although general anesthesia with
single lung ventilation is required.15
Endobronchial one-way valve devices have been
used to alter respiratory dynamics and achieve lung
volume reduction in patients with advanced em-
physema.18–20 In this study, we experimentally
evaluated the ability of the endobronchial valve
device in treating surgically created air leak or
pneumothorax by eliminating antegrade flow.Methods
Experimental procedure
Six sheep (mean weight 35 kg) received intravenous
atropine, ketamine, and diazepam and underwent
endotracheal intubation and general anesthesia
using inhalational isofluorane (1–4%) (Hallowell
EMC Model 2000, Pittsfield, MA). The animals had
electrocardiographic, oxygen saturation, and fe-
moral arterial line monitoring. A left thoracotomy
was made at the fourth interspace. The anterior
mediastinal pleura was divided and the right cranial
lobe identified. A 2.5 cm (long) 1.5 cm (deep)
laceration was made in the cranial lobe with
resultant air leak. Bronchoscopy was performed
using a Pentax flexible bronchoscope (Pentax FB-
19x, Tokyo, Japan). The bronchus to the right
cranial lobe was identified. A balloon catheter
(Arrow International 6 Fr balloon wedge pressure
catheter, Reading, PA) was placed via the working
channel into the segmental bronchus, the balloon
inflated and the degree of air leak assessed. If the
air leak continued, the balloon catheter was placed
into another segmental bronchus in the craniallobe. This was repeated until the bronchus leading
to the injured segment was identified as evidenced
by air leak resolution. An estimate of the size of the
target bronchus was made with the balloon
inflated. After deflating and removing the balloon
catheter, a 0.03500 flexible tip guidewire was passed
through the working channel of the bronchoscope
and the distal tip of guidewire situated in the
target segmental bronchus. The bronchoscope was
removed with the guidewire left in place. The valve
device within the deployment apparatus (Emphasys
Medical, Inc., Redwood City, CA) was loaded onto
the guidewire, the bronchoscope was reinserted
and the device directed into the target bronchus.
The device was deployed followed by removal of
the deployment apparatus and guidewire. After
assuring the integrity of the valve device, the
bronchoscope was removed. The tidal volume was
increased so that the peak inspiratory pressure was
40 cmH2O to assess the degree of residual air leak.
A 14 Fr chest tube was placed at the fifth
interspace and the thoracotomy closed. The sheep
emerged from anesthesia and extubated. The chest
tube was aspirated every 15min and removed if
there was no air leak and drainage. The animals
received one intramuscular dose of enrofloxacin
(5mg/kg) (Bayer Pharmaceutical, West Haven, CT)
at the time of the initial procedure and maintained
on oral enrofloxacin (5mg/kg/day) during the
follow-up period. The animals were sacrificed at 1
week (n ¼ 3) and 1 month (n ¼ 3) after initial
thoracotomy and device implant. The animals
underwent general anesthesia with induction using
intravenous telazol and endotracheal intubation
and inhalational isofluorane (1–4%). Bronchoscopy
was performed to visualize the valve device. The
animals underwent right thoracotomy and the area
of lung injury and degree of lung collapse eval-
uated.Device
The endobronchial valve device, designed to be
placed over a guidewire under bronchoscopic
guidance, is composed of a one-way valve, a seal,
a valve protector, and a retainer (Fig. 1). The
silicone one-way valve is mounted onto a nitinol
protector and bonded inside the seal, which acts as
a barrier between the valve and the wall of the
bronchial lumen. The protector prevents compres-
sion of the seal by the bronchial wall. The retainer,
constructed of a self-expanding nitinol mesh and
designed to resist device migration, expands to
contact the wall of the bronchial lumen. In order to
account for variations in bronchial luminal diameter,
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Figure 2 Intraoperative photograph of atelectasis of a
right lung segment at 1 month follow-up.
Figure 1 The self-expanding one-way valve device is
loaded into a capsule and is designed to be placed over a
guidewire and directed into the target bronchus using
bronchoscopy. The device is deployed by retracting the
capsule operated by a handle at the end of the catheter.
J.I. Fann et al.1404there are three available sizes: 4.0–5.5, 5.0–7.0 and
6.5–8.5mm. Should the device not be optimally
situated at or subsequent to the time of implant or if
the patient later develops an infectious complica-
tion, the valve device may be removed using
bronchoscopic graspers.
The use of laboratory animals in this protocol was
approved by the animal care committee at the
institution. All animals received humane care in
compliance with the ‘‘Guide for the Care and Use of
Laboratory Animals’’ prepared by the Institute of
Laboratory Animal Resources, National Research
Council, and published by the National Academy
Press (revised 1996).Results
All six animals survived thoracotomy, creation of air
leak and valve implant procedure. During broncho-
scopy, the segmental bronchus leading to the
injured lung is usually identified with one or two
separate inflations of the balloon catheter. Place-
ment of the valve device with bronchoscopic
guidance was successful in all animals and required
no more than 10min. The chest cavity was filled
with water confirming resolution of air leak in the
injured region (at peak inspiratory pressure of
40 cmH2O). The size of the implanted valve deviceswas 6.5–8.5mm in all animals. After closure of
thoracotomy incision, the chest tube demonstrated
minimal drainage (less than 50 cc) and no air leak in
all animals. The chest tube was removed within 3 h
after operation. No animal developed hypoxemia,
bronchospasm, or respiratory distress during or
after the procedure. In the follow-up period, none
of the animals had clinical evidence of pneumonia,
and supplemental oxygen therapy or intubation was
not required in any animal.
At 1 and 4 weeks after initial thoracotomy and
valve placement, fiberoptic bronchoscopy showed
no change in device location; the valves devices
were intact and well seated in the bronchial lumen.
At thoracotomy, all animals showed atelectasis of
the treated segment distal to the device with
fibrous reaction in the region of the lung injury
(Fig. 2). Because the second operation was per-
formed via a right thoracotomy, no adhesions were
appreciated except in the injured region.Discussion
Bronchoscopic techniques aimed at closing a
persistent bronchopleural fistula have been em-
ployed in the postoperative setting and involve the
use of glues and sealants, sclerosing agents, stents,
plugs, balloons, coils, submucosal injection of
ethanol, or a combination thereof.6–14 These less
invasive approaches must be individualized since
there is no one optimal method. Embolization coils
may be associated with gaps between the coils and
inadequate sealing. Fibrin and synthetic glues may
be difficult to employ and usually are more
successful in treating smaller fistulas. Combining
coils and glue have been successful in obliterating
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Submucosal injection with ethanol can result in
good healing; however, this technique is not always
successful, particularly in larger defects.6,10
In most patients with post-traumatic pneu-
mothorax, early treatment includes tube thora-
costomy, adequate volume resuscitation, and serial
chest radiographs.15–17 If the lung fails to re-expand
after tube thoracostomy, major airway injury
should be suspected, diagnosed with bronchoscopy,
and treated. If the pneumothorax persists after
tube thoracostomy, Carrillo et al. have used video-
assisted thoracoscopic surgery to successfully re-
pair the lung injuries.15 This technique provides a
good evaluation of the degree of pulmonary trauma
and is a safe alternative to an open thoracotomy;
nonetheless, general anesthesia and single lung
ventilation are required.
Endobronchial one-way valve devices have been
employed as a less invasive means to achieve lung
volume reduction in selected patients with ad-
vanced emphysema, resulting in improved func-
tional status and quality of life and relief of
dyspnea at early follow-up.18–20 In this study, we
found that placement of the endobronchial valve
device reliably treated an iatrogenic air leak by
creating collapse of the affected lung segment.
Follow-up at 1 week and 1 month demonstrated
healing of the injured region and resolution of
pneumothorax. In order for this technique to be
effectively employed in the clinical setting, it is
important to identify the segment or lobe in the
region of lung injury. Using temporary balloon
inflation, one can identify the involved portion of
the lung by noting whether the degree of air leak
via the chest tube has diminished or ceased. This
bronchoscopic approach holds promise in providing
an effective nonsurgical, less invasive alternative
to the management of persistent air leak in
patients with bronchopleural fistula or post-trau-
matic lung injury. Although the endobronchial valve
devices can be placed in the experimental setting
with evidence of healing in the injured region, the
long-term outcome using such a technique is
unknown and awaits the results of ongoing clinical
experience.
This study was directed at evaluating the ability
of the valve devices to eliminate air leak created
surgically. One limitation of this study is that the
animals were not models of emphysema. Thus, in
patients with advanced chronic obstructive lung
disease, it may be difficult to resolve the air leak by
simple placement of an endobronchial valve, since
collateral channels in these patients would con-
tribute to the persistence of air leak. Because
infection is often associated with chronic bronch-opleural fistula, the introduction of a foreign body
is of concern and the ability to subsequently
remove the device has been demonstrated in the
clinical setting. The potential advantage of a one-
way valve device is that should there be ongoing
infection distal to the device, the valve may
provide for drainage.Acknowledgements
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